In the brain tumor context, preliminary data from Damodar et al showed the evidence that fenretinide was able to affect human MB cell viability in vitro, inducing apoptosis mediated by the activation of caspase-3 and supported by the cleavage of PARP-1 [18], even if more detailed mechanisms and molecular targets have not been investigated. Here, CASP3 is linked to brain neoplasm.